Matrix Hyaluronan-Activated CD44 Signaling Promotes Keratinocyte Activities and Improves Abnormal Epidermal Functions  by Bourguignon, Lilly Y.W.
The American Journal of Pathology, Vol. 184, No. 7, July 2014
AS
IP
20
14
AJ
P
CM
E P
rog
ramajp.amjpathol.orgMINI-REVIEW
Matrix Hyaluronan-Activated CD44 Signaling Promotes
Keratinocyte Activities and Improves Abnormal Epidermal
Functions
Lilly Y.W. BourguignonFrom the Department of Medicine, University of California at San Francisco, and the Endocrine Unit, VA Medical Center, San Francisco, California
CME Accreditation Statement: This activity (“ASIP 2014 AJP CME Program in Pathogenesis”) has been planned and implemented in accordance with the Essential Areas and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the
American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this journal-based CME activity (“ASIP 2014 AJP CME Program in Pathogenesis”) for a maximum of 48 AMA PRA Category 1 Credit(s). Physicians should
only claim credit commensurate with the extent of their participation in the activity.
CME Disclosures: The authors of this article and the planning committee members and staff have no relevant ﬁnancial relationships with commercial interests to disclose.Accepted for publicationC
P
hMarch 18, 2014.
Address correspondence to
Lilly Y. W. Bourguignon,
Ph.D., Department of Medicine,
University of California at San
Francisco, and Endocrine Unit
(111N), VA Medical Center,
4150 Clement St, San
Francisco, CA 94121. E-mail:
lilly.bourguignon@ucsf.edu.opyright ª 2014 American Society for Inve
ublished by Elsevier Inc. All rights reserved
ttp://dx.doi.org/10.1016/j.ajpath.2014.03.010Hyaluronan (HA), a major component of the extracellular matrix, is enriched in skin tissues, particularly
the epidermis. HA binds to a ubiquitous, abundant, and functionally important family of cell surface
receptors, CD44. This article reviews the current evidence for HA/CD44-mediated activation of
RhoGTPase signaling and calcium mobilization, leading to the regulation of keratinocyte activities and
various epidermal functions. It further discusses the role of HA-mediated CD44 interactions with unique
downstream effectors, such as RhoGTPases (RhoA and Rac1), Rho-kinase, protein kinase-Ng, and
phosphoinositide-speciﬁc phospholipases (phospholipases Cε and Cg1) in coordinating certain intra-
cellular signaling pathways, such as calcium mobilization, phosphatidylinositol 3-kinaseeAKT activa-
tion, cortactin-actin binding, and actin-associated cytoskeleton reorganization; generating the onset of
important keratinocyte activities, such as cell adhesion, proliferation, migration, and differentiation;
and performing epidermal functions. Topical application of selective HA fragments (large versus small
HA) to the skin of wild-type mice (but not CD44 knockout mice) improves keratinocyte-associated
epidermal functions and accelerates permeability barrier recovery and skin wound healing. Conse-
quently, speciﬁc HA fragment (large versus small HA)emediated signaling events (through the CD44
receptor) are required for keratinocyte activities, which offer new HA-based therapeutic options for
patients experiencing epidermal dysfunction and skin damage as well as aging-related skin diseases,
such as epidermal thinning (atrophy), permeability barrier dysfunction, and chronic nonhealing
wounds. (Am J Pathol 2014, 184: 1912e1919; http://dx.doi.org/10.1016/j.ajpath.2014.03.010)Supported by US Department of Veterans Affairs Merit Review Awards
RR and D-1I01 RX000601 and BLR and D-5I01 BX000628, US Public
Health grant R01 CA66163, and US Department of Defense grant
W8IXWH-11-2-0189. L.Y.W.B. is a VA Senior Research Career Scientist.
Disclosures: None declared.In the epidermis, extracellular matrix (ECM) components
form an integral part of the hemidesmosomes and mediate
keratinocyte attachment to the underlying basement mem-
brane. Matrix hyaluronan (HA) is the major glycosamino-
glycan in the ECM of most mammalian tissues, including
epidermis and dermis,1,2 and HA has been implicated in
several skin epidermal functions.1,2 However, the cellular
and molecular mechanism by which keratinocytes respond
to HA is not fully understood.stigative Pathology.
.HA and CD44 in Epidermal Keratinocytes
The predominant receptor for HA on the cell surface of
keratinocytes is CD44.3 CD44 is encoded by a single gene
HA/CD44 Signaling in Epidermal Functionsthat contains 19 exons.4 The most common form, CD44
standard form, contains exons 1 to 5 (N-terminal 150 amino
acids), exons 15 and 16 (membrane proximal 85 amino
acids), exon 17 (transmembrane domain), and a portion of
exons 17 and 19 (cytoplasmic tail, 70 amino acids).4 Of the
19 exons, 12 can be alternatively spliced.4 Most often, the
alternative splicing occurs between exons 5 and 15, leading
to an insertion in tandem of one or more variant exons (exon
6 to exon 14; v1 to v10) within the membrane proximal
region of the extracellular domain.4 For example, keratino-
cytes contain the additional exons v3 to v10 inserted into the
CD44 standard form transcripts.5 This isoform has been
designated as CD44v3-10 (or Epican).5 Several lines of
evidence indicate that the HA-CD44 interaction selects
unique downstream effectors and coordinates intracellular
signaling pathways that initiate a concomitant onset of
multiple cellular functions.6
Transgenic mice expressing an antisense construct to
CD44 in their skin or traditional CD44 knockout mice show
a signiﬁcant reduction in endogenous HA on the keratino-
cyte cell surface and the loss of certain keratinocyte func-
tions.7 Both CD44 and endogenous HA are expressed in the
epidermal keratinocytes of CD44 wild-type mouse skin.7 No
CD44 and little endogenous HA can be detected in the
epidermal keratinocytes of CD44 knockdown or CD44
knockout mouse skin.7 Furthermore, several keratinocyte
differentiation markers, such as involucrin and ﬁlaggrin,
appear to be signiﬁcantly reduced in the skin of CD44
knockdown or CD44 knockout mice, compared with CD44
wild-type mice.7 These ﬁndings suggest that both HA and
CD44 play an important role in normal epidermal physio-
logical and keratinocyte functions (eg, differentiation). The
CD44 deﬁciency is accompanied by a reduction in HA
staining in CD44 knockout mouse skin and marked alter-
ations in keratinocyte barrier function, proliferation, differ-
entiation, and lipid synthesis, resulting in altered barrier
function.7 Down-regulation of CD44 in cultured keratino-
cytes (using CD44 siRNA) also signiﬁcantly inhibits HA-
mediated keratinocyte differentiation and lipid synthesis.7
These observations indicate the importance of both CD44
and HA for several key epidermal keratinocyte functions.HA/CD44-Mediated RhoA and Rac1 Signaling in
Keratinocytes
Members of the Rho subclass of the Ras superfamily
[small-molecular-weight GTPases (eg, RhoA, Rac1, and
Cdc42)] act as molecular switches that alternate between
GTP- and GDP-bound states. The activated GTP-bound
enzymes preferentially interact with downstream effector
molecules that modulate effector activities.8 For example,
activation of RhoA and Rac1 signaling has been shown to
be involved in cell growth, survival, cytoskeleton-
associated migration, and cell-cell adhesion, as well as
keratinocyte differentiation.9e11The American Journal of Pathology - ajp.amjpathol.orgRhoA-Activated ROK Signaling Events
Previous work has indicated that HA promotes the interaction
between CD44 and several Rho-speciﬁc guanine nucleotide
exchange factors (eg, p115RhoGEF12 and LARG13) that up-
regulate RhoA (a member of the Rho subclass of the Ras su-
perfamily), leading to several important cellular functions.12,13
Several enzymes have been identiﬁed as possible downstream
targets for RhoGTPases (eg, RhoA) regulating cytoskeleton-
mediated cell motility.9e11 One such enzyme is Rho-kinase
(ROK; also called Rho-binding kinase), a serine-threonine
kinase.14,15 ROK interacts with RhoA in a GTP-dependent
manner14,15 and is composed of four functional domains: a
kinase domain (catalytic site), a coiled-coil domain, a Rho-
binding (RB) domain, and a pleckstrin-homology (PH)
domain.14,15 Both the kinase and RB domains share a large
percentage of sequence homology with a family of related
kinases known to bind Rho GTPase and participate in cell
motility and cytoskeleton functions.16Truncationof the kinase
domain at the N-terminal region results in the inhibition of
kinase activity, loss of stress ﬁbers, and reduction in focal
adhesion complexes.14,15 Point mutations of either RB or PH
domains at the C-terminal region of ROK have been shown to
block the formation of stress ﬁber and focal adhesion.14e16
These observations suggest that the RB or PH domain plays
an important role in regulating ROK activation.
RhoA/ROK-Regulated Cytoskeleton Pathway
The actin cytoskeleton has been shown to coordinate and sta-
bilize adhesive structures and modulate epidermal shape
changes and motility.17 ROK activity is essential for ROK’s
involvement in promoting stress ﬁber formation and focal
adhesion complexes.16 Microinjection of an expression vector
encodingROK results in the formation of stressﬁbers and focal
adhesion complexes in certain cell types.14e16 In keratinocytes,
the polarized cytoskeleton is dependent on RhoA-activated
ROK to orchestrate polarized cytoskeletal architecture in the
early steps of assembling a stratiﬁed epithelium.17 ROK has
also been shown to phosphorylate several cellular substrates,
including myosin light chain phosphatase18 and LIM kinase.19
Phosphorylation of myosin light chain phosphatase and LIM
kinase by RhoA-activated ROK results in actomyosin
contractility and actin assembly-disassembly, respectively18,19
(Figure 1A).Keratinocytemigration and differentiation require
RhoA-activated ROK signaling.10,11,20 Loss of RhoA sig-
naling signiﬁcantly decreases directed keratinocyte migra-
tion.11 Further analyses indicate that the N-terminal region of
ROK is needed for the proper regulation of its activity.14e16
Overexpression of either the RB domain or the PH domain
(dominant-negative forms) of ROK by transfecting cells with
RB cDNAor PH cDNAblocks HA/CD44-speciﬁc phenotypic
changes.21,22 These observations indicate that the RB or PH
domain plays an important role in regulating ROK activation.
In addition, inhibition of RhoA-activated ROK by Y27632
treatment effectively blocks the HA/CD44-induced keratino-
cyte signaling and functions.23 Selective activation of CD441913
Figure 1 A proposed model for HA/CD44-mediated signaling in keratinocytes. The binding of HA to the extracellular domain of CD44 promotes activation of
RhoGTPases [eg, RhoA (A) and Rac1 (B)], which then generate speciﬁc signaling cascades described as follows. A: RhoA-speciﬁc signaling pathways. HA-CD44
interaction (left, 1) activates RhoA-ROK signaling, promotes the membrane localization of Gab-1, and activates certain isoforms of PI3K, leading to AKT activa-
tion and keratinocyte cell growth and survival. The binding of HA to CD44 induces activation of ROK, which, in turn, phosphorylatesmyosin light chain phosphatase
and LIM kinase, thereby generating actomyosin contractility and actin assembly-disassembly required for keratinocyte migration (left, 2). HA-CD44emediated ROK
signaling also phosphorylates PLCε (left, 3) which, in turn, produces IP3 production and IP3 receptoretriggered intracellular Ca
2þmobilization, resulting in CaMKII
activation. CaMKII then phosphorylates the cytoskeletal protein, ﬁlamin, leading to cytoskeleton reorganization and keratinocyte migration. B: Rac1-speciﬁc
signaling pathways. HA-CD44 interaction activates Rac1 signaling and PKN activity (right, 1). Activated PKN then phosphorylates certain cellular proteins,
including PLC-g1, which, in turn, produces IP3 production and IP3 receptoretriggered intracellular Ca
2þmobilization, resulting in CaMKII activation. CaMKII then
phosphorylates the cytoskeletal protein, ﬁlamin, leading to cytoskeleton function and keratinocyte differentiation. The binding of HA to CD44 also promotes PKN-
mediated phosphorylation of cytoskeletal protein, cortactin, thereby generating actin ﬁlament reorganization and keratinocyte cell-cell adhesion (right, 2).
Bourguignonsignaling by different sizes ofHA fragments has been shown to
induce RhoA-ROK pathway-speciﬁc effects on keratinocyte
functions (eg, proliferation and/or migration).23 RhoA-
activated ROK also phosphorylates the cytoplasmic domain
of the CD44v3 isoform and up-regulates the interaction be-
tween the CD44v3 isoform and the cytoskeletal protein,
ankyrin, during breast tumor cell migration.21 Thus, ROK is
one of the important signaling molecules participating in HA-
mediated CD44 function.21
RhoA/ROK-Regulated Gab-1, PI3K, and AKT Pathway
The epidermis continuously undergoes self-renewal, prolif-
eration, survival, and differentiation. Grb-2eassociated
binder-1 (Gab-1), a member of the insulin receptor substrate
family,12,24 and phosphatidylinositol 3-kinase (PI3K)24 are
key mediators in regulating epidermal cellular functions,
such as proliferation and cell survival.12,24 Speciﬁcally, Gab-1
functions as one of the major adapter molecules downstream
of growth factor signaling.24,25 Gab-1 also possesses multiple
phosphorylation sites that could act as docking sites for PI3K,
which is known to consist of a catalytic subunit p110 (a, b,
and d) and a regulatory subunit p85 (a, b, and p55g), or
the catalytic subunit p110g and the regulatory subunit1914p101.24,25 PI3K signaling to AKT promotes keratinocyte
differentiation.26
A previous study also found a positive link between HA-
CD44 interaction and Gab-1eassociated PI3K activation
during the stimulation of cellular transformation.12 Specif-
ically, HA activates PI3K-AKT pathways, leading to cell
motility and cell survival signaling pathways.12 The active
mutant of the p110 subunit of PI3K exerts its action on the
cleavage of CD44 during cell migration.27 These ﬁndings
suggest PI3K activation is closely coupled with
HA-mediated CD44 signaling. The binding of HA to cells
stimulates ROK activity, which, in turn, increases serine/
threonine phosphorylation of the adaptor protein, Gab-1.24
Phosphorylated Gab-1 promotes PI3K recruitment to
CD44v3.12 Subsequently, PI3K is activated (particularly, a,
b, and g forms, but not the d form of the p110 catalytic
subunit), AKT signaling occurs, and cell growth and survival
are up-regulated. HA/CD44-mediated PI3K activity and
AKT activation can be effectively blocked by a PI3K in-
hibitor (LY294002).12 These observations support the notion
that PI3K activation and HA/CD44 signaling are functionally
coupled. Finally, overexpression of a dominant-negative
form of ROK (by transfection of cells with ROK’s RBajp.amjpathol.org - The American Journal of Pathology
HA/CD44 Signaling in Epidermal Functionsdomain cDNA) not only inhibits HA/CD44-mediated RhoA-
ROK activation and Gab-1 phosphorylation, but also down-
regulates oncogenic signaling events (eg, Gab-1/PI3K-CD44
association and PI3K-mediated AKT activation) and cellular
behaviors (eg, cell growth and survival).12
CD44v3 contains not only HA binding sites, but also
displays the heparin sulfate addition site, which involves the
binding of growth factors, cytokines, and chemokines. It is
likely that HA/CD44-regulated ROK (under the inﬂuence of
other growth factors, cytokines, and chemokines) plays a
pivotal role in the phosphorylation of both CD44v3 and
Gab-1 phosphorylation, leading to ankyrin binding and
Gab-1ePI3K membrane localization and AKT signaling,
respectively, during HA-mediated functions (Figure 1A).
Rac1-Activated PKN Signaling Events
HA also promotes the interaction between CD44 and several
Rac1-speciﬁc guanine nucleotide exchange factors (eg,
Tiam128 and Vav229) that up-regulate Rac1 (another mem-
ber of the Rho subclass of the Ras superfamily), leading to
altered cytoskeleton-mediated cell functions.28,29 Several
enzymes have been identiﬁed as possible downstream ef-
fectors for Rac1 signaling. One such enzyme is protein ki-
nase N (PKN), which is closely related to the protein kinase
C family in their conservative catalytic domains (C-terminal
regions) while differing in their N-terminal regulatory
domains.30e33 The three known isoforms, PKN 1, 2, and 3,
are closely related, exhibiting greatest variation with their
regulatory domains. In particular, PKN2 (alias PRK2) be-
longs to a family of serine-threonine kinases known to
interact with Rac1 in a GTP-dependent manner.30e33 The
N-terminal region of PKN2 contains three homologous se-
quences of approximately 70 amino acids (relatively rich in
charged residues), which form an antiparallel coiled-coil
fold (ACC domain).30e33 This ACC domain interacts with
RhoGTPases, such as RhoA and Rac1 (and, to a lesser
extent, with Cdc42).30e33 Moreover, PKN has been found
to regulate intermediate ﬁlaments, such as vimentin, glial
ﬁbrillary acidic protein, and other neuroﬁlament proteins.34
In keratinocytes, Rho-activated PKN (PRK2) has been
found to be involved in Fyn/Src kinaseeregulated cell-cell
adhesion during Ca2þ-induced differentiation.35 Rac1-
PKN2 (to a lesser extent RhoA-PKN2) appears to be pref-
erentially activated by HA-CD44 signaling. However,
RhoA-PKN2 appears to be stimulated by high Ca2þ treat-
ment. Because HA (but not high Ca2þ) is naturally present
in the skin, we believe that HA-induced Rac1-PKN2 is more
physiologically relevant to keratinocytes.HA-CD44 Interaction Regulates Intracellular
Ca2D Signaling and Keratinocyte Functions
The epidermis is characterized by a polarized pattern of
keratinocyte growth (ie, dividing cells detected at the basalThe American Journal of Pathology - ajp.amjpathol.orglayer of the epidermis) and differentiation (ie, differentiated
cells distributed as multiple overlying layers throughout the
epidermis). Mouse primary keratinocytes cultured in low
Ca2þ medium (0.03 to 0.07 mmol/L) proliferate actively,
with little contact inhibition, and resemble undifferentiated
basal epidermal cells.36 Keratinocyte differentiation can be
induced by adding high concentrations of Ca2þ (0.12 to 2.0
mmol/L) to these cultures.36 Previous studies indicated that a
multiphasic increase in intracellular Ca2þ concentration after
the addition of exogenous 1 to 2 mmol/L Ca2þ to keratino-
cytes is required for Ca2þ-induced keratinocyte differentia-
tion.36 Inhibition of intracellular Ca2þ mobilization by
treatment with a Ca2þ chelator, 1,2-bis (aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid, prevents Ca2þ-induced
differentiation.36,37 These ﬁndings suggest that intracellular
Ca2þ mobilization plays a critical role in regulating kerati-
nocyte differentiation. The early events of keratinocyte
differentiation (within hours of the Ca2þ switch) involve
cytoskeletal rearrangement and the expression of keratino-
cyte differentiation markers, including keratins K1, proﬁ-
laggrin (the precursor of ﬁlaggrin, an intermediate ﬁlament-
associated protein), involucrin, and loricrin (a precursor for
the corniﬁed envelop). Within 24 to 48 hours after the Ca2þ
switch, transglutaminase is activated and tightly cross-
linked with loricrin, involucrin, and other proteins into the
insoluble corniﬁed envelop of mouse keratinocytes.36
In addition to externally added Ca2þ, keratinocyte
growth and differentiation can also be regulated by several
agents, including phorbol esters, retinoic acid, vitamin D3,
and matrix HA. In particular, HA-CD44 binding appears
to stimulate the elevation of intracellular Ca2þ levels in
keratinocytes and induces keratinocyte differentiation.32
Recent studies indicate that RhoGTPases are also in-
volved in the regulation of intracellular Ca2þ levels in
normal keratinocytes32 and transformed keratinocytes13
during cellular functions.
HA/CD44-Mediated RhoA Activation and Ca2þ
Signaling
A previous study showed that HA binding to CD44 induces
RhoA-speciﬁc guanine nucleotide exchange factor, the
leukemia-associated Rho guanine nucleotide exchange fac-
tor (LARG), and RhoA signaling in transformed keratino-
cytes.13 In searching for possible new cellular targets of
LARG-activated RhoA, phosphoinositide-speciﬁc phos-
pholipase Cε (PLCε) was identiﬁed. Speciﬁcally, it has been
observed that HA-CD44 binding stimulates LARG-
catalyzed RhoA signaling, which, in turn, activates the
RhoA association with PLCε in a GTP-dependent manner
and promotes PLCε-mediated inositol 1,4,5 triphosphate
(IP3) production and Ca
2þ mobilization.13 Subsequently, the
up-regulation of Ca2þ/calmodulin-dependent kinase-II
(CaMKII) occurs, leading to phosphorylation of the cyto-
skeletal protein, ﬁlamin. The phosphorylation of ﬁlamin
reduces its interaction with ﬁlamentous actin, promoting1915
Bourguignontumor cell migration. Further analyses show that the PDZ
domain of LARG binds to CD44 directly. Transfection of
the head and neck tumor cells (HSC-3 cells) with LARG-
PDZ cDNA signiﬁcantly reduces LARG association with
CD44. Overexpression of the LARG-PDZ domain functions
as a dominant-negative mutant (similar to the PLC/CaMKII
inhibitor effects) by blocking HA/CD44-mediated signaling
events (eg, RhoA activation, PLCε-mediated IP3 production,
intracellular Ca2þ mobilization, CaMKII activity, ﬁlamin
phosphorylation, and ﬁlamin-actin binding) and abrogating
tumor cell migration13 (Figure 1A). These ﬁndings indicate
that CD44 interaction with LARG plays a pivotal role in
RhoA activation and PLCε-Ca2þ signaling required for
CaMKII-mediated cytoskeleton function, resulting in trans-
formed keratinocytes.13
HA/CD44-Mediated Rac1 Activation and Ca2þ Signaling
HA-CD44 interaction also induces Rac1-PKN phosphory-
lation of PLCg1 and cortactin in cultured keratinocytes.32
Speciﬁcally, the Rac1-activated PKN (induced by HA-
CD44 binding) increases threonine (but not serine) phos-
phorylation of PLCg1 and up-regulates PLCg1 activity,
leading to the onset of intracellular Ca2þ mobilization. HA/
CD44-activated Rac1-PKN also phosphorylates the cyto-
skeletal protein, cortactin, at serine/threonine residues.32
The phosphorylation of cortactin by Rac1-PKN attenuates
its ability to cross-link ﬁlamentous actin in vitro. Further
analyses indicate that the N-terminal ACC domains of PKN
interact directly with Rac1 in a GTP-dependent manner. The
binding of HA to CD44 induces PKN association with
endogenous Rac1 and its activity in keratinocytes. Trans-
fection of keratinocytes with PKN-ACC cDNA reduces
HA-mediated recruitment of endogenous Rac1 to PKN and
blocks PKN activity. These ﬁndings demonstrate that the
PKN-ACC fragment acts as a potent competitive inhibitor
of endogenous Rac1 binding to PKN in vivo. Most impor-
tant, the PKN-ACC fragment functions as a strong
dominant-negative mutant that effectively inhibits HA/
CD44-mediated PKN phosphorylation of PLCg1 and cor-
tactin, as well as keratinocyte signaling (eg, Ca2þ mobili-
zation and cortactin-actin binding) and cellular functioning
(eg, cell-cell adhesion and differentiation). Taken together,
these ﬁndings strongly suggest that HA-CD44 interaction
with Rac1-PKN plays a pivotal role in PLCg1-regulated
Ca2þ signaling (Figure 1B) and cortactin-cytoskeleton
function (Figure 1B), both of which are required for kera-
tinocyte cell-cell adhesion and differentiation. Because
large HA fails to activate Rho-PKN2, it is not clear what the
role of Rho-PKN2 is in large HA-CD44 signaling. It is
possible that other sizes of HA (eg, small or intermediate
sizes of HA) are involved in the selective activation of Rho-
PKN2 and downstream targets (PLCg1). The question of
whether these two pathways (Rac1-PKN2 versus Rho-
PKN2) represent complementary cross talk or competition
awaits further investigation.1916HA and CD44 in Normal and Aged Epidermis
Skin aging is a universal and inevitable process character-
ized by physiological alterations in keratinocyte activities
and epidermal functions, as well as dermal changes.38 Aged
skin is often associated with retraction of rete ridges/pegs
and a ﬂattening of the epidermal-dermal junction.7,23,38 In
particular, thinning of the epidermis in aged skin is closely
associated with decreased keratinocyte proliferation.23,39
Skin aging also results in delayed wound healing, partially
due to reduced keratinocyte migration.40 Although the
stratum corneum maintains a relatively constant thickness
throughout life, aged epidermis is often characterized by
abnormal barrier function, impaired lipid synthesis, and
aberrant lamellar body formation and secretion.7,23,41
Epidermal dysfunction and abnormal keratinocyte activ-
ities in aged skin often lead to debilitating clinical conse-
quences [eg, epidermal thinning (atrophy), barrier
dysfunction, xerosis/xerotic eczema, delayed wound heal-
ing, and inﬂammation] and increased morbidity in elderly
persons, which includes altered drug permeability,
increased susceptibility to ulceration, and irritant contact
dermatitis.38 At the present time, the cellular and molecular
mechanisms causing epidermal dysfunction associated with
skin aging are not well understood. However, recent studies
now reveal that abnormal HA metabolism may be involved
in the changes associated with keratinocyte activities,
permeability barrier homeostasis, and wound healing during
skin aging processes and disease progression.
HA Metabolism and Skin Aging
HA within the epidermis (and, to a lesser extent, the dermis)
has been found to rapidly turn over.42,43 These observations
suggest that epidermis is able to catabolize HA that is closely
coordinated with its synthesis and degradation. Under
physiological conditions, HA is synthesized by several HA
synthases,44 and HA fragments of low molecular mass are
produced by hyaluronidases or oxidation.45 One general
concept that has emerged from these studies is that HA
fragments [small HAs (HAS)] and their larger precursor
molecules [large HAs (HAL)] may include distinct biological
activities.23,46e48 This process may involve the recruitment
of biologically active ECM fragment (HAS with a mol. wt. of
approximately 1  105 to 1  104 Da) from the intact ECM
(HAL with a mol. wt. of >1  106 Da) during periods of
proliferation, migration, differentiation, and development, as
well as injury-related repairs.41e45 Several studies indicate
that HAL (>1  106 Da) promotes transcriptional activation
and differentiation, whereas HAS (1  105 to 1  104 Da)
induces proliferative genes and migration.41 HA fragmenta-
tion may also play a key role in the sequential phases of tissue
injury and repair,46 but the cellular mechanisms underlying
their action are not clearly deﬁned. An age-related decrease in
HA production has been found in both rodent42 and human
aged skin.43 Age-related changes in the sizes of HA have alsoajp.amjpathol.org - The American Journal of Pathology
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associated with impaired wound healing40 and the delayed
resolution of a variety of skin diseases.38e41 All of these
observations are consistent with the notion that both low
levels of HA deposition and HA size modiﬁcations could
contribute to skin aging, impaired wound healing, and dis-
ease progression.
Topical Application of HA Fragments and Anti-Skin
Aging Effects
Most research on skin aging has focused on the effects of
photoaging on the dermis. However, effective therapeutic
options available to correct the aging-related changes in
epidermal keratinocyte activities remain limited. A recent
study indicates that small HA fragments (HA tetrasaccha-
tides) are capable of inducing epidermal differentiation
through phosphorylation of CD44 in keratinocyte culture
in vivo.49 However, the question of whether these HA
tetrasacchatides can promote CD44 signaling and improve
epidermal function during skin aging is not known. A
previous study by Brown et al50 showed that topical
application of HA fragments (labeled by [3H]-hyaluronan)
can penetrate through both mouse and human skin via
active transport (not passive diffusion). Thus, the pene-
tration of HA fragments in mouse skin does not present a
technical problem. Therefore, it is possible to design
corrective HA-based therapeutic strategies for the treat-
ment of skin aging-related diseases.Figure 2 A proposed model for selective effects of HAS versus HAL on CD44-m
signaling in aged skin: In epidermis, HAS binding to CD44 promotes RhoA-ROK si
epidermal thickness and acceleration of wound healing in aged skin. ROK inhib
variety of keratinocyte functions (eg, proliferation, migration, epidermal thicknes
signaling in aged skin: In epidermis, HAL binding to CD44 promotes Rac1-PKN sig
leading to restoration of permeability barrier functions in aged skin. PKN inhibit
variety of keratinocyte functions (eg, cell-cell adhesion, differentiation, lipid synth
and CD44 deﬁciency in knockout (k/o) mice cause down-regulation of HAS-me
resulting in abnormal epidermal structure and function.
The American Journal of Pathology - ajp.amjpathol.orgCurrently, the cellular and molecular mechanisms involved
in epidermal dysfunction and skin aging are not well under-
stood. Nevertheless, HA and its catabolic products are known
to selectively activate CD44-mediated keratinocyte signaling
that regulates keratinocyte proliferation, migration, differen-
tiation, lamellar body formation/secretion, and wound heal-
ing, all of which involve RhoGTPases (eg, RhoA and
Rac1).23 As previously mentioned, a recent study indicates
that changes in the HA size distribution and CD44 expression
are closely associated with reduced RhoA/Rac signaling and
marked alterations in epidermal functions, resulting in dele-
terious consequences for the permeability barrier function and
wound healing in aged epidermis. Further analyses indicate
that HAS activates CD44-dependent RhoA/ROK signaling,
whereas HAL activates CD44-speciﬁc Rac1/PKN signaling,
leading to distinctly different keratinocyte functions and re-
sponses. Down-regulation of ROK and PKN by treating the
mouse skin with Y27632 and Ro31-8220, respectively, also
greatly reduces sequential HA (HAS/HAL)-mediated
epidermal functions and permeability barrier recovery.23
Furthermore, topical application of HAS promotes kerati-
nocyte proliferation and increases skin thickness, but it fails to
up-regulate keratinocyte differentiation or permeability barrier
repair in agedmouse skin (Figure2A). In contrast,HAL induces
only minimal changes in keratinocyte proliferation and skin
thickness, but restores keratinocyte differentiation and im-
proves permeability barrier function in aged epidermis23
(Figure 2B). Because neither HAS nor HAL corrects these
epidermal defects in aged CD44 knockout mice, it is likely thatediated epidermal functions during skin aging. A: HAS-mediated RhoA-ROK
gnaling, resulting in proliferation and migration, leading to an increase in
itor, Y27632, effectively reduces HAS-mediated RhoA-ROK signaling and a
s, and skin wound healing) in aged mouse skin. B: HAL-mediated Rac1-PKN
naling, resulting in cell-cell adhesion, differentiation, and lipid synthesis,
or, Ro31-8220, effectively reduces HAL-mediated Rac1-PKN signaling and a
esis, and permeability barrier function) in aged mouse skin. Both skin aging
diated RhoA-ROK signaling and HAL-induced Rac1-PKN activation events,
1917
BourguignonCD44 mediates HA-associated epidermal functions in aged
mouse skin. Finally, the blockade of Rho-kinase activity with
Y27632 (Figure 2A) or protein kinase-N activity with Ro31-
8220 (Figure 2B) signiﬁcantly decreased the HA (HAS or
HAL)-mediated changes in epidermal function in aged mouse
skin. These ﬁndings demonstrate that HA application of
different sizes regulates epidermal proliferation, differentiation,
and barrier function in aged mouse skin; and that manipulation
of matrix (HA) interaction with CD44 and RhoGTPase sig-
naling could provide novel therapeutic approaches targeted at
the treatment of various aging-related skin disorders.
Conclusions
In summary, we suggest that HA activation of CD44
signaling induces pathway (RhoA-ROK versus Rac-
PKNg)-speciﬁc effects on diverse epidermal processes (eg,
Gab-1eassociated PI3K-AKT activation, Ca2þ signaling,
actomyosin activities, and actin-ﬁlament reorganization),
leading to a variety of epidermal functions (eg, proliferation,
survival, migration, cell-cell adhesion, differentiation, and
epidermal barrier formation) in keratinocytes. Furthermore,
activation of CD44 signaling (via HAS versus HAL or
HAS/HAL) induces pathway (RhoA-ROK versus Rac-
PKN)-speciﬁc effects on diverse epidermal processes (eg,
epidermal proliferation, skin thickness, differentiation, and
epidermal barrier formation) in aged mouse epidermis. These
newly discovered HA/CD44-signaling events provide the
opportunity to develop novel HA-based therapeutic
approaches for use in the treatment of patients experiencing
several aging-related skin diseases (eg, skin atrophy, psori-
asis, atopic dermatitis, actinic keratoses, and chronic non-
healing wounds). Signaling perturbation agents (eg, Y27623,
a ROK inhibitor) may also be applied to patients with certain
skin diseases involving up-regulation of keratinocyte prolif-
eration (eg, psoriasis and actinic keratosis) r to correct the
imbalance between RhoA-ROK signaling and Rac1-PKNg
activation during epidermal aging and various skin diseases.
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